AI Regulation
Trump Administration Signals Hands-Off Approach to AI Regulation, Advisor Confirms No 'FDA for AI'
A White House adviser recently confirmed that a potential future Trump administration would not establish an "FDA for AI," signaling a preference for a less centralized and regulatory-heavy approach to artificial intelligence governance. This stance underscores a consistent philosophy prioritizing innovation and private sector leadership over the creation